Home>Topics>Companies>Express Scripts

Express Scripts ESRX

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Exclusive: Express Scripts presses for more drug savings with coverage list

      Headlines

      Tue, 23 Dec 2014

      LOS ANGELES (Reuters) - Express Scripts , the largest manager of prescription drug plans for U.S. employers, is taking an increasingly aggressive stance in price negotiations

    2. UPDATE 3- Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival

      Headlines

      Mon, 22 Dec 2014

      Dec 22 (Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount.

    3. RPT-UPDATE 2- Express Scripts drops Gilead hep C drugs for cheaper AbbVie rival

      Headlines

      Mon, 22 Dec 2014

      Dec 22 (Reuters) - The largest U.S. pharmacy benefit manager said on Monday it has lined up a cheaper price for AbbVie Inc's newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc's treatments after trying for nearly a year to win a deeper discount.

    4. Any thoughts on GILD - Gilliad Sciences

      Commentary

      Mon, 22 Dec 2014

      It has tanked more than 10% this morning on the news that Express Scripts will buy HEp-C drugs from AbbVie only. Is it a good time to add to the current position or dump the shares? Thanks - SAM

    5. US STOCKS-Futures advance after three-day rally; data on tap

      Headlines

      Mon, 22 Dec 2014

      * Gilead falls as Express Scripts chooses AbbVie treatment

    6. US STOCKS-Futures climb after three-day run

      Headlines

      Mon, 22 Dec 2014

      * Gilead falls as Express Scripts chooses AbbVie treatment

    7. AbbVie's Viekira Favored by Express Scripts Over Gilead's Harvoni; Maintaining Our FV Estimates

      Commentary

      Mon, 22 Dec 2014

      the U.S. market. In addition, Express Scripts announced Dec. 22 that Sovaldi ..... Viekira's list price, according to Express Scripts ). We’re not making any changes ..... discounts) to AbbVie in 2015. Given Express Scripts ' roughly 30% share of U.S. prescriptions

    8. Express Scripts to cover AbbVie hepatitis C drug, drops Gilead treatment

      Headlines

      Mon, 22 Dec 2014

      Dec 22 (Reuters) - The nation's largest pharmacy benefit manager has lined up a cheaper price from AbbVie Inc on its newly approved hepatitis C treatment and, in most cases, will no longer cover Gilead Sciences Inc treatments, Express Scripts said on Monday.

    9. Express CFO to Leave in January, Replaced by Major Brands CFO James Havel

      Commentary

      Tue, 16 Dec 2014

      On Dec. 15, Express Scripts announced that CFO Cathy Smith will leave the firm in January and be replaced on an interim basis by James Havel, the current CFO

    « Prev12345Next »
    Content Partners